There is no better tap than Intellia Therapeutics Inc (NTLA) Stock
Goldman lowered the price target for the Intellia Therapeutics Inc (NASDAQ:NTLA) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $66. The stock was initiated by Bernstein, who […]
Intellia Therapeutics Inc (NASDAQ:NTLA) stock is trading 26.28 percent above its 52-week low
Goldman lowered the price target for the Intellia Therapeutics Inc (NASDAQ:NTLA) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $66. The stock was initiated by Bernstein, who […]
Is it possible to sustain this rally? Intellia Therapeutics Inc (NTLA) Stock
Goldman lowered the price target for the Intellia Therapeutics Inc (NASDAQ:NTLA) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $66. The stock was initiated by Bernstein, who […]
Intellia Therapeutics Inc (NASDAQ:NTLA) stock is trading -50.29 percent below its 52-week high
Goldman lowered the price target for the Intellia Therapeutics Inc (NASDAQ:NTLA) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $66. The stock was initiated by Bernstein, who […]
Why Intellia Therapeutics Inc (NASDAQ:NTLA) Stock Increased 3.70 percent in recent Trade?
Goldman lowered the price target for the Intellia Therapeutics Inc (NASDAQ:NTLA) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $66. The stock was initiated by Bernstein, who […]
In the current cycle, Intellia Therapeutics Inc (NTLA) Stock is showing signs of growth
Goldman lowered the price target for the Intellia Therapeutics Inc (NASDAQ:NTLA) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $66. The stock was initiated by Bernstein, who […]
Risks and Returns of Intellia Therapeutics Inc (NTLA) Stock
Goldman lowered the price target for the Intellia Therapeutics Inc (NASDAQ:NTLA) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $66. The stock was initiated by Bernstein, who […]
What Are the Chances of Intellia Therapeutics Inc (NTLA) Stock Making a Comeback?
Goldman lowered the price target for the Intellia Therapeutics Inc (NASDAQ:NTLA) stock from “a Buy” to “a Neutral”. The rating was released on February 23, 2024, according to finviz. The research report from Canaccord Genuity has initiated the stock to Buy, with a price target set at $66. The stock was initiated by Bernstein, who […]
